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Background: The face of international aid for health and development is changing. Private donors such as
foundations and corporations are playing an increasingly important role, working in international development as
direct operators or in partnerships with governments. This study compares maternal health programs of new
development actors to traditional governmental donors. It aims to investigate what maternal health programs large
governmental donors, foundations and corporate donors are conducting, and how and why they differ.
Methods: A total of 263 projects were identified and analyzed. We focus on nine categories of maternal health
programs: family planning services, focus on specific diseases, focus on capacity building, use of information and
communication technology (ICT), support of research initiatives, cooperation with local non-state or state partners
and cooperation with non-local non-state or state partners. Data analysis was carried out using Generalized Linear
Mixed-Effects Models (GLMER).
Results: Maternal health policies of public and private donors differ with regard to strategic approaches, as can
be seen in their diverging positions regarding disease focus, family planning services, capacity building, and
partner choice. Bilateral donors can be characterized as focusing on family planning services, specific diseases and
capacity-building while disregarding research and ICT. Bilateral donors cooperate with local public authorities and
with governments and NGOs from other developed countries. In contrast, corporations focus their donor activities
on specific diseases, capacity-building and ICT while disregarding family planning services and research. Corporations
cooperate with local and in particular with non-local non-state actors. Foundations can be characterized as focusing on
family planning services and research, while disregarding specific diseases, capacity-building and ICT. Foundations
cooperate less than other donors; but when they do, they cooperate in particular with non-state actors, local as
well as non-local.
Conclusions: These findings should help developing coordination mechanisms that embrace the differences and
similarities of the different types of donors. As donor groups specialize in different contexts, NGOs and governments
working on development and health aid may target donors groups that have specialized in certain issues.
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Foreign aid from private sources is changing the land-
scape of international development assistance, adding to
the work of traditional donors such as bilateral and
multilateral organizations. Private donors are playing an
increasingly important role, working on international de-
velopment issues as direct operators, in partnership with
governments and with international NGOs as grant pro-
viders. At the beginning of the twenty-first century, there
are more philanthropic and corporate foundations holding
more assets in more countries than ever before [1].
Funding priorities have increasingly come under scru-
tiny from the scientific community [2-5]. However, look-
ing at funding allocations alone is not sufficient to assess
the role of private actors in development. In fact, it is es-
sential to get an understanding of their basic operating
models and policies at the project level [6]. It is being
assumed that organizations choose their projects accord-
ing to their overall strategies and goals. Moreover, by
looking at projects and not just formulated goals and
strategies, the paper analyzes what types of maternal
health projects are actually being conducted by the do-
nors. This often provides a more accurate picture about
the strategic priorities than official mission statements.
In the complex new donor landscape, mechanisms for
coordination, information sharing and planning are cru-
cial for effective development aid [7,8]. Knowing about
differences and understanding them are critical precon-
ditions for effective cooperation, collaboration and part-
nership, as it can be expected that the new actors come
with different expertise and approaches. However, such a
comparison of private and bilateral donors has not been
conducted yet.
This study seeks to fill this research gap by analyzing
the health programs of large bilateral donors, founda-
tions and corporate donors in the area of maternal
health, which can be defined as the health of “mothers
and babies during pregnancy, childbirth and the postpar-
tum period” [9]. Maternal health has become a focus
area of the World Health Organization (WHO), as the
death of a mother has long-term destabilizing effects on
family and community structures in most developing
countries [10]. Other focus areas of the WHO, such as
HIV/AIDS or other infectious diseases, have already
been studied for decades and clear funding and project
preferences of public and private donors have been
carved out. This is not the case for more long-term and
less visible health issues such as maternal health. Thus,
our analysis of maternal health projects broadens our
understanding of donor preferences. Additionally, inter-
national and bilateral norm promotion and resource
transfer are important drivers of domestic maternal
health prioritization in developing countries, as Shiffman
points out for several countries [11]. Moreover, thelevels of maternal mortality are regarded as sensitive in-
dicators of the entire health system, since interventions
in these areas require a functioning health system to
have an effect at the population level [12].
In this study, we delineate maternal health programs
along nine categories: family planning services, focus on
specific diseases, focus on capacity building, use of infor-
mation and communication technology (ICT), support
of research initiatives, cooperation with local non-state
or state partners and cooperation with non-local non-
state or state partners. The objects of analysis constitute
263 maternal health projects by fifteen donors that were
conducted within the time frame between June 2012 and
June 2013. The fifteen donors include the most re-
sourceful five donors per category: bilateral/government,
philanthropic foundations and corporate donors. The
geographic focus of the projects was restricted to middle
and low-income countries in Africa, Latin America,
Oceania and Asia.
Methods
The reason for using five bilateral donors, five founda-
tions, and five corporate donors is that when choosing
the largest donors from each group (measured by spend-
ing) and comparing their programs, it is possible to draw
some conclusions on the likelihood that differences in
policy design are due to donor characteristics. Obviously,
the representativeness of the findings for smaller organi-
zations is limited. However, it still might be possible to
generalize. This assumption rests upon the fact that
large organizations exert influence on the direction of
aid and the priorities of organizations in general.
In our analysis, projects are the response variable and
donor type is the predictor variable. Individual donor or-
ganizations enter the analysis as a grouping factor that
represents unobserved organizational effects.
For bilateral donors, the OECD/DAC International
Development Statistics (IDS) online database was used.
We selected bilateral donors according to their commit-
ments for total health and population policies/programs
& reproductive health which include all maternal health
interventions. This leads to the five largest bilateral do-
nors: United States, United Kingdom, Canada, Australia
and Germany.
Determining the largest foundations working in the
area of maternal health is more challenging, since there
is no global database with uniform spending data of
foundations. The largest foundations organized by total
amount of giving in 2011 were chosen according to total
spending, because no sub data for maternal health pro-
grams were available. This sample selection procedure
rests on the assumption that the largest donors also
spend the most on maternal health projects. There
might be smaller foundations, such as the MacArthur
Table 1 Number of projects per donor group and by
donor
Bilateral Foundations Corporations
USA 41 Packard Foundation 26 Merck 24
UK 40 Ford Foundation 15 Johnson & Johnson 11
Canada 25 Gates Foundation 13 Sanofi Espoir Found 9
Australia 20 Hewlett Foundation 12 Novartis Foundation 4
Germany 15 Wellcome Trust 6 Abbott Fund 2
Total 141 Total 72 Total 50
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health.a However, in order to systematically select our
sample we have to rely on comparable data. Two spend-
ing databases were taken into consideration: the Global
Health Visions Landscape Analysis from 2011 and the
US Foundation Center database from 2013. The five
largest foundations were: the Bill and Melinda Gates
Foundation, the Wellcome Trust, the Ford Foundation,
the William and Flora Hewlett Foundation and the David
and Lucile Packard Foundation. All of these foundations
are grant making foundations. It was assumed that they
are only funding projects that are aligned with their prior-
ities. However, only grants for specific projects or pilot
studies were included in the analysis, not grants for gen-
eral support or organizational development of grantees, in
order to enable a better comparison with bilateral donors.
Aid expenditures of corporations were analyzed using
the Global Health Visions Landscape Analysis [13], re-
search conducted by Christine Dugay [14], a report by
Population Services International [15], and the members
list of the Partnership for Maternal, Newborn and Child
Health [16]. The five largest corporate donors were
Johnson & Johnson, Merck and the Merck Company
Foundation, the Abbott Fund, the Novartis Foundation
for Sustainable Development and the Sanofi Espoir
Foundation.
The first step in estimation of donor differences was
to identify all relevant maternal health programs. The
first criterion in the case selection procedure was to
establish whether the goal of improving maternal health
was included in the project name or description. Mater-
nal health is inextricably linked to reproductive health
and there are a number of definitions available for the
two concepts [13]. The “Components of a Safe Mother-
hood Package” [17] served as a guideline for which
specific interventions to include if maternal health was
not stated as a goal in the project description, although
it still appeared obvious that the project was a maternal
health project. Programs regarding the prevention of
mother-to-child transmission of HIV were not taken
into account, since these mostly address the health of
the child (although they have a positive effect on the
mother’s health) and the issue of priorities in HIV/AIDS
projects is a different topic. Newborn and child health
were also often addressed in maternal health projects,
but with these topics, only maternal health policies were
analyzed. Furthermore, general health system strength-
ening projects were also not included, even though they
indirectly affect the mother’s health, since only direct ef-
fects were of interest. Additionally, large product donation
partnerships, awareness raising campaigns, coordination
networks or alliances/coalitions such as the WHO-based
Partnership for Maternal, Newborn and Child Health that
act globally were not taken into account if they did notconduct tangible projects. Contributions by bilateral do-
nors to multilateral organizations were not included for
the same reason. The grant amount or project costs were
also not of interest, as these constitute a different kind of
analysis that doesn’t focus on actual policies. Public-
Private Partnerships were also not a major focus of this
analysis, as the differences between donor groups were of
main interest instead. We furthermore restricted the geo-
graphic focus of projects to Latin America, Africa, Asia
(except for Russia) and Oceania (except for Australia and
New Zealand). Projects in North America and Europe
were excluded; for example, grants from a foundation to
an US grantee for promoting a maternal health campaign
in the U.S., for organizational development of a European
NGO or for organizing a conference on maternal health.
We identified 263 maternal health projects that matched
our criteria (See Table 1).
Data on the maternal health projects was collected on
the agencies’ or foundations’ websites. The project data-
bases provide information such as project description, de-
tails about recipients and time periods. Moreover, spot-
checks were made with the AidData website [18], a project
run by several universities and non-profits to serve as a
registry of aid activities to improve transparency.
We focus on nine categories of maternal health
programs:
 Family planning services (FP) are defined as
education, counseling and contraceptive
commodities provided on a voluntary basis to
females and couples [19,20]. FP services were coded
with 1 if the services were actually offered, or if
there was research, advocacy or consultation about
it, as this means that the donor approves these
programs. It may be that in some cases when
maternal health services were listed in the project
description, this included FP services. However, they
were only coded with 1 if they were explicitly
mentioned in the project description.
 Disease-specific approaches were coded with 1 if a
concrete disease or medical condition was mentioned
in the project description (e.g. fistula, postpartum
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malaria in pregnancy).
 Capacity-building approach is a process by which
individuals, institutions and countries strengthen
capacities or abilities, such as enhancing the skills,
knowledge and social capabilities available to
individuals, institutions, and social and political
systems [21].
 Use of ICT means “the acquisition, analysis,
manipulation, storage and distribution of
information; and the design and provision of
equipment and software for these purposes” [22].
ICT goods are intended to fulfill the function of
information processing and communication by
electronic means [23,24].
 A project was rated as providing support for
research initiatives if it clearly stated in the project
description that research was conducted, which is
thought to be anything that involves scientific research
methods, including pilot studies or tests of tools.
 Cooperation with local partners (state) and
cooperation with local partners (non-state): A local
partner is defined as being from and headquartered
in the country where the project takes place in
comparison to multilateral organizations or global
NGOs that have country offices in many regions but
still receive direction from their headquarters.
 Cooperation with non-local non-state actors
(NSAs) and governments: This category includes
donors’ work with other NSAs and governments
that are not from the country where the project is
located.
Data analysis was carried out using Generalized Linear
Mixed-Effects Models (GLMER) available in the R pro-
gramming environment within the packages nlme [25].
Such models provide an efficient means to model item
level responses clustered within groups. As in every lin-
ear model, a GLMER describes the relationship between
a response variable and certain covariates. In a mixed ef-
fects model, at least one of these covariates is categorical
and represents a grouping factor. In this essay, the
fifteen organizations were treated as a grouping factor.
Random effects can be interpreted as representing unob-
served random variables within the grouping factors such
as unobserved organizational effects [25]. The GLMER
estimates intercepts for each level of the grouping factor,
in this case for every donor. Models also estimate the
between donor variance which can be interpreted as the
residual variability that is left over and that cannot be
attributed to either the grouping factor or the fixed effects.
In contrast, fixed effects represent the average (estimated)
relationship between response and covariates. This pro-
vides the average or population model. In this analysis, wemodel the effects using the binomial family of the GLMER
framework. Thus, we are interested in the probability that
donor type has an effect on the design of a certain project.
Results
The following section provides an overview of the dif-
ferent maternal health projects by donor groups using
the different categories of analysis. As can be seen from
Figure 1 and Table 2, donor groups differ substantially
in most aspects of maternal health programs. Regarding
some aspects, however, within-group variation is often
high indicating small between-group differences.
Figure 1 and Table 2 highlight the substantial dimen-
sions of maternal health projects. The first aspect involves
family planning services. As it turns out, 42% of all donors
include family planning services in their projects, with
bilateral donors comprising the highest amount (52%). In
comparison, foundations and corporations included sig-
nificantly less family planning services in their project
portfolios (see Table 2). 32% of foundations’ projects and
only 14 percent of projects by corporations included such
services (see Figure 1).
Twenty-one percent of bilateral donors’ projects are
disease-specific, in comparison to 16 percent of corpor-
ate projects and four percent of foundation projects.
Only the difference between bilateral donors and foun-
dations is statistically significant. On the individual
donor level, the United States stands out, as almost half
of their many projects (19 of 41) are disease-specific. A
more detailed analysis shows that those are mostly inter-
ventions to address malaria in pregnancy, nutrition
problems during pregnancy, maternal anemia and post-
partum hemorrhage. USAID’s Maternal and Child Health
Integrated Program (MCHIP) uses “evidence-based inter-
ventions” to improve maternal health in four main areas
that are mostly disease-specific: prevention of postpartum
hemorrhage; prevention and treatment of preeclampsia/
eclampsia; prevention of maternal anemia, and expanding
access to and improving the capacity of skilled birth
attendants. They also aim to promote the integration of
FP, malaria and HIV/AIDS activities within maternal
health programs [26]. Excluding USAID significantly
reduces the percentage of disease-specific projects in
the group of bilateral donors, resulting in a figure only
half as high.
Concerning capacity-building, bilateral donors (61%)
and especially corporations (84%) have a stronger focus
on this area (Figure 1). In contrast, only 26% of founda-
tion projects involve capacity-building. In general, it is
noteworthy that over half of all donors (56%) include
capacity-building components. Looking at private donors,
exactly 50 percent of their projects include capacity-
building. Within the group of bilateral donors, the UK
stands out, with only 20 percent of their projects including
Figure 1 Substantive and cooperative dimensions of donor projects (in % per donor type).
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of 60 percent or more. As for foundations, half of the pro-
jects of the Hewlett and Ford Foundation have capacity-
building components, but the remaining foundations have
little mention of capacity-building. All of the corporate
donors, on the other hand, have these components in
three quarters or more of their projects.
Few maternal health projects have a focus on imple-
menting ICT. This is particularly true for bilateral do-
nors, from which only the US included ICT components
in their projects (about 33%). One third of all corporate
donors also work in this area compared with only ten
percent of foundations. Most of USAID’s ICT interven-
tions in maternal health focus on using mobile technol-
ogy to deliver behavioral change messages to mothers or
mentoring to maternal health workers, through public-
private partnerships such as MAMA (Mobile Alliance
for Maternal Action) or the mHealth Alliance (mPowering
Frontline Health Workers). The Gates Foundation in-
cluded ICT in only two of their 13 projects. Except for theTable 2 Estimates of donor effects on the substantial dimens
Family planning
services
Disease specifi
approach
Random effects
Between donors (within donors) 1.07 (1.03) 0.71 (0.84)
Fixed effects
(Intercept) −0.14 (0.50) −1.83*** (0.47)
Corporations −1.31# (0.77) 0.09 (0.75)
Foundations −2.36** (0.90) −1.50# v
AIC 310.2 207
Note: Values are GLMER coefficients; standard errors are in parentheses.
***p < 0.001, **p < 0.01, *p < 0.05, #p < 0.1.Abbott Fund and Johnson & Johnson, all corporate donors
are strongly involved in ICT projects, especially the
Novartis Foundation, through interventions such as e-
learning tools or ICT referral systems in rural areas. This
is underlined by the fact that the use of new technologies
such as e-learning or mHealth is one of the foundations’
five approaches, adopted to deploy a business mindset and
outcome-based thinking [27].
Eighteen percent of all donors include a research
component in their projects. Foundations incorporate a
research aspect in 40 percent of their projects. The
percentage share for bilateral donors is ten, and for cor-
porate donors six. As for individual bilateral donors,
Australia (25%) and the US (17%) conduct some re-
search projects. In contrast, all foundations are involved
in research projects. The coefficient for foundations is
highly significant. All of the Wellcome Trust’s projects
involve a research component, since health research is
the main focus of the organization. Furthermore, the
Hewlett and the Gates Foundation are also heavilyion of projects
c Capacity building
approach
Use of ICT Support of research
initiatives
1.02 (1.01) 1.44 (1.20) 1.24 (1.11)
0.70 (0.50) −3.68*** (0.80) −2.67*** (0.62)
1.42# (0.85) 2.71** (1.05) −0.30 (1.06)
−1.85* (0.74) 1.31 (1.05) 2.66** (0.85)
288.7 184.4 205.6
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research projects by foundations is already very high, it
could have been even higher if global research alliances,
networks or development partnerships without concrete
projects would have been included. The Gates Founda-
tion’s commitment to research, in particular, focuses on
the development of new drugs, vaccines and diagnostics,
which is generally not included in this analysis as this
does not occur at a project level [28].
Figure 1 and Table 3 highlight the partnership dimen-
sion of maternal health projects. Partnerships with local
and international organizations are prevalent in most
projects. Looking at all donors together, 53 percent of all
projects involve a local partner. This is a relatively low
number, considering the 2005 Paris Declaration on Aid
Effectiveness which aims to achieve more national own-
ership. All donors work almost equally together with
state (23%) and non-state partners (21%), although with
a much smaller combination of both (9%). Fifty-seven
percent of bilateral donors and only 44 percent of foun-
dations work together with local partners, in comparison
to 56 percent of corporate donors. 49 percent of private
donor projects have a local partner, which is less than
with public actor projects. As for bilateral donors, the
most common local partners are state institutions (33%),
followed by NSAs (13%) and a combination of state and
non-state partners (11%). However, these differences are
statistically not significant (see Table 3). The random
effects indicate that the between donor variability of
having a local partner is rather low and superimposed by
a higher within donor variability. That means that most
donors do not show a clear profile themselves.
The most common local partners of foundations are
non-state institutions (32%), with state actors only being
involved in 13 percent of the projects. Corporations
work with almost the same amount of states (10%) and
NSAs (30%) as foundations, but work more with a com-
bination of both (16%) and therefore have a higher share
of local partners.Table 3 Estimates of donor effects on the cooperation dimen
Any local partner Local partne
non-state
Random effects
Between donors (within donors) 0.86 (0.93) 0.47 (0.68)
Fixed effects
(Intercept) 0.45 (0.46) −1.38*** (0.3
Corporations 0.15 (0.73) 1.39* (0.59)
Foundations −0.76 (0.68) 0.30 (0.57)
AIC 347.8 315.8
Note: Values are GLMER coefficients; standard errors are in parentheses.
***p < 0.001, *p < 0.05, #p < 0.1.Regarding local partners, corporations work signifi-
cantly more with non-state organizations than bilateral
donors (see Table 3). Especially the Novartis and Sanofi
Espoir Foundations have many partnerships with non-
state organizations. Similarly, foundations work significantly
less with public partners. Two foundations in particular
have noteworthy partnership strategies (see Table 4): the
Gates Foundation involves local partners in only 8 percent
of their projects, by far the lowest number of total local
partner involvement of all 15 donors. The Ford Foundation,
in contrast, gives 73 percent of their overall grant-making
in this area to local institutions, most of them also non-
state. This confirms the findings of a study by Chervalier
and Zimet [29], which compares twelve foundations
and their grant recipients. According to them, the Ford
Foundation favors direct partnerships with institutions
in the global South, in comparison to the Gates, Hewlett
and Packard Foundations. Differences between founda-
tions and bilateral donors with regard to involvement with
local non-state organizations as compared to corporations
and bilateral donor’s involvement with local public organi-
zations are statistically not significant.
All donors work with non-local, non-state partners.
Corporations do so for most projects (64%), followed by
bilateral donors (54%) and foundations (49%). Since
within-donor group variance is quite large, these results
are statistically not significant. The random effects
indicate that the between donor variability of having a
local partner and the within donor variability are almost
equally high. As a result some donors as well as donor
types have no clearly defined profile. Regarding bilateral
donors, the United States conducts all its projects with a
non-local, non-state partner. All USAID’s Maternal and
Child Health Integrated Program projects are conducted
by a core set of partners that come from a pool of eight
NGOs or corporations. More concretely, all projects
involved the partner Jhpiego, and very often also PATH,
Save the Children and John Snow Inc. USAID further
collaborates with many additional partners, such assion of projects
r Local partner state Cooperation
non-local NGO
Cooperation
non-local state
2.85 (1.69) 1.19 (1.09) 1.56 (1.25)
8) −0.18 (0.78) 0.15 (0.54) −0.37 (0.59)
−0.95 (1.20) 0.51 (0.82) −0.90 (0.93)
−2.12# (1.18) −0.31 (0.77) −1.80# (0.92)
263.2 324.2 292.9
Table 4 The cooperation dimension of projects (in % for each organization)
Any local partner Local partner
non-state
Local partner state Cooperation
non-local NGO
Cooperation
non-local state
% % % % %
Australia 60 10 55 25 70
Canada 32 16 16 60 40
Germany 93 13 80 27 13
United States 76 23 18 27 45
United Kingdom 36 42 68 100 42
Ford Foundation 73 60 13 33 0
Gates Foundation 8 8 0 69 31
Hewlett Foundation 42 8 33 58 0
Packard Foundation 46 46 0 50 4
Wellcome Trust 50 0 50 17 67
Abbott Fund 50 50 0 100 0
Johnson Johnson 36 36 0 64 55
Merck 50 42 8 67 4
Novartis 75 50 75 50 75
Sanofi 100 78 89 56 11
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ships. As for Canada, non-local, non-state partners were
mostly Canadian NGOs. These two bilateral donors
confirm the assumption that many bilateral donors have
long-standing relationships with their home-country de-
velopment actors as the main intermediaries for funds
to support development. However, not all bilateral
donors work in the same way; Australia, Germany and
the UK only work with home-country NSAs in one
third of their projects. Hence, the high number of
bilateral projects with non-local NSAs is largely driven
by the US and Canada. Foundations worked with the
least amount of non-local NSAs, although they still
work with many. Their usual types of non-state partners
are akin: mostly international NGOs, a few private re-
search institutions and very few corporations. Many of
these partners are US-based, as are four of the five
foundations.
Thirty-one percent of all donors’ projects involve a
non-local public partner. Bilateral donors lead the rank-
ing (43%), followed by corporations (22%). Foundations
only have very limited cooperation with non-local public
donors (13%). The difference between foundations and
bilateral donors is statistically significant. Bilateral do-
nors all work with non-local public actors; some less
(Germany, 13%) and some more (Australia, 70%). In
the case of Australia, those public donors are other
bilateral agencies or multilateral donors. As for Canada,
the UK and the US, public partners are mostly multilat-
eral organizations (e.g. UNICEF, WHO, World Bank).
Regarding foundations, the Wellcome Trust works withnon-local public actors in two thirds of their projects.
The Gates Foundation does so in one third, and the
remaining three foundations work with (almost) no
non-local public partner. By excluding the Wellcome
Trust, only eight percent of foundations’ projects have a
non-local public partner. Finally, concerning corporate
donors, the Novartis Foundation and Johnson & Johnson
work extensively together with non-local public actors
(75% and 55%, respectively). However, Novartis only con-
ducted four projects in total. Multilateral organizations
could be a preferred partner for the same reasons, as they
have established field presence in many countries. This cat-
egory can be compared to the number of local public part-
ners. By looking at all donors together, more work with
non-local (31%) than with local public partners (23%).
This may be due to a reliance on home-country public
research institutions, other donor agencies and multilat-
eral organizations – all important actors in the patchwork
of international donors. The largest difference is in the
group of corporations (22% non-local vs. 10% local part-
ners) followed by bilateral donors (43% non-local vs. 33%
local partners). The foundations’ work with non-local and
local public partners is equally distributed (13%). At an
individual level, exceptions are in Germany (80% local
and only 13% non-local public partners), with the Gates
Foundation (31% non-local and no local public partners)
and with the Abbott Fund (no public partner at all).
Figure 1 shows that the majority of all projects rather
included non-state partners than public actors (69%
compared to 51%). Especially the private actors did so,
with foundations showing the largest difference.
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In the results section, we identified typical profiles of
donor project characteristics. Bilateral donors can be
characterized as focusing on family planning services,
specific diseases and capacity-building while, in compari-
son, disregarding research and ICT. Bilateral donors co-
operate with local public authorities and with governments
and NGOs from other developed countries. In contrast,
corporations focus their donor activities on specific dis-
eases, capacity-building and ICT while disregarding family
planning services and research. Corporations work to-
gether with local and in particular with non-local non-state
actors. Foundations can be characterized as focusing on
family planning services and research, while disregarding
specific diseases, capacity-building and ICT. Foundations
cooperate less than other donors; but when they do, they
cooperate in particular with non-state actors, local as well
as non-local.
These profiles partly match donor funding patterns.
Regarding bilateral donors, development funding has
changed in the last decade. In particular, the development
discourse of government aid agencies and international
organizations has altered preferences of bilateral donors
[30]. Historically, governments focused their assistance on
specific countries and regions on grounds of economic
and political interests, historical ties or geographical prox-
imity. Since the end of the cold war, the preferences have
shifted towards perceived needs of developing countries.
The intention was to have a lasting impact on the root
causes of suffering, rather than alleviate suffering in the
short term. As a result, a capacity-building approach
became the strategy of choice, rather than handing out,
for example, food aid [30]. Additionally, the sector-wide
approach (SWAP) emerged in the 1990s, a specific model
of cooperation in which donors agree to pool resources
within some specific sector, supporting a single sector pol-
icy and expenditure program under government leader-
ship [31]. Recent developments, however, indicate that
bilateral donor governments are increasingly being chal-
lenged by taxpayers in their countries to become more
accountable and transparent in their spending practices.
At the bilateral level, donors are beginning to restrict
health aid flows, putting renewed emphasis on impact, co-
financing and value for money [4]. As a result, vertical
(disease-specific) programs have reemerged and donors in-
creasingly support these programs because these programs
are easier to monitor and evaluate, and their results are
available more quickly [32]. Furthermore, McCoy and
Kinyua find no relationship between total health ex-
penditure and government expenditures on health of a
recipient country and the amount of funding granted
by bilateral donors [5]. According to a WHO Bulletin
paper, half of the additional funding between 2000 and
2009 targeted only two diseases: HIV and malaria[33,34]. Maternal health projects mirror these develop-
ments. Bilateral donors focus on capacity-building and,
at the same time, on disease-specific projects. This
combination ensures long-term effects of bilateral aid and
makes effects measurable as is the case with disease-
specific projects [35].
Regarding family planning services, the historical
rationale for public involvement in family planning (FP)
provision is based on the negative externalities associ-
ated with high rates of population growth. For example,
the United States has a strong history of supporting FP
as part of its foreign assistance programs [19]. However,
this support has been fraught with challenges and there
has been an enduring gap in US policy approaches on
this issue [19]. According to Ruth Levine, USAID’s FP
program has suffered more than any other program
from being a “political football” [36]. This has, among
other factors, been caused by the perceived linkage of FP
to the highly charged issue of abortion. However, as it
turns out, we did not detect a “political football” effect
for family planning services. Quite the contrary, even
the US projects involve a family planning component in
most instances which includes family planning counsel-
ing and training with local health care workers. It seems
that US projects avoid taking inroads into the social and
political minefield on the issue of abortion.
Regarding cooperation with local and foreign organiza-
tions, public donors often have well-established relation-
ships with particular developing countries that provide a
basis for dialogue and cooperation, written down in offi-
cial country agreements [37]. This form of cooperation
is further shaped by the principles of current aid strat-
egies based on the 2005 Paris Declaration. Two of the
five principles in the Declaration are particularly import-
ant to mention here: national ownership and alignment
[38]. For many bilateral donors, civil society is seen to
play an important role in helping build country ownership
of aid policies, as they have come to realize that national
ownership should mean more than state ownership. Two
developments support this trend. First, many donors are
looking for more in-country contextual analysis and many
mention the importance of conducting mapping exercises,
in order to better understand the social and political
landscape of recipient countries and make more informed
partner choices. Second, due to this emphasis on southern
civil society and the desire to fulfill the Paris Declaration
principles, a rising interest in establishing in-country
multi-donor funding mechanisms can be observed.
These ‘pooled funds’ go to locally contracted and granted
projects in the south, often to fund civil society organiza-
tions [38].
Philanthropic donors are extremely diverse but share
some common characteristics. First, foundations are
“perhaps among the most unaccountable organizations
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or customers [1]. In comparison to NGOs and corpora-
tions, they are not dependent on donations and do not
have to compete on a market [30]. This is the reason for
their signature characteristic: the capacity to be innova-
tive and creative, take risks, act as an alternative to the
state and provide long-term, unrestricted support for
those ‘beyond’ the market and the state [1,3,6]. As our
results indicate, research-based activities are indeed a
primary focus of philanthropic donors, which to our
surprise do not involve much ICT.
Corporate donors have shareholders and customers
and are therefore not as independent as foundations.
Key components that influence corporate giving prior-
ities are enhancing corporate image, increasing brand
recognition, introducing new products into the market,
giving back to communities where they have a presence
and, also, identifying a niche [13]. Corporations are largely
seen to be concerned with issues that directly benefit the
corporation’s stakeholders or promote the corporation’s
business objectives [39,40]. Generally, it has been argued
that as private donors do not need to consider priorities
such as foreign policy, they can hence select projects on
the basis of need and focus on problem-solving [6]. As
with business, private donors also like to know the impact,
including social returns, of their investments in develop-
ment. Hence shareholders demand development results
[41]. These two issues, the problem-oriented behavior and
the will to be able to show results, lead to a trend of keep-
ing overheads low and identifying key indicators of per-
formance and impact. It is the corporations’ goal that their
funding and efforts have the greatest impact possible [6].
This ‘business-like approach’ encourages the transfer of
successful strategies, management techniques and princi-
ples from the for-profit sector to international develop-
ment. They emphasize solving problems, taking risks,
fostering innovation and measuring success [6]. Private
donors are therefore increasingly focused on finding tech-
nical solutions to clearly identified problems, also leading
to vertically delivered, disease-specific programs [41].
They often return to projects merely providing equipment
or technology, e.g. vaccinations, new water systems or bed
nets. Maternal health projects confirm these studies, in
that their projects are disease-specific and have a focus on
technical solutions such as ICT. However, the findings of
Marten and Witte, that corporations show a preference
for vertically-organized programs due to dysfunctional
local structures that project implementers sometimes
face [6], cannot be confirmed here. Corporations in-
clude capacity-building in 4 out of 5 maternal health
projects.
Foundations and corporations usually work outside of
state structures and, by and large, their programs are not
connected to national development strategies. Therefore,if they have local partners, these are mostly non-state
partners [6,40]. However, private donors often struggle
with the complexities of finding capable and suitable
partners on the ground with whom to work [3]. As a re-
sult, they show a preference for non-local NGOs. The
reasons for this can be found in strong relationships to
home-country non-state development actors such as
grant recipients and in problems with finding suitable
partners in the project country. This raises questions of
local ownership and alignment with national policies.
Skeptics point out that the marginal involvement of re-
cipient country governments raise questions of sustain-
ability. In terms of process, it can be argued that in
some cases, bypassing the government is an unsustain-
able approach [2]. Working with governments and thus,
strengthening the health system, might be the most effi-
cient in the long term. However, this is difficult in the
short term, and therefore, bypassing government and go-
ing straight to communities can potentially result in
more immediate impact [2]. Private donors prefer quick
results and measuring success, which can explain the
preferred partner choice. However, it needs to be stated
that there is less but, of course, still some cooperation
with local and public actors.
There may be limitations to our findings. First, our
study focuses on the largest donors regarding maternal
health programs. We argue that large donors exert
influence on the direction and the priorities of aid.
However, this does not mean that smaller donors have
similar priorities in terms of e.g. cooperation partners
or ICT utilization. Second, our sample has a strong bias
towards the US and the Anglosphere. As a result,
variation between donors might be largely driven by
cultural or political factors peculiar to the Anglo-Saxon
and US world. It is plausible to assume that donors
from other countries such as France or China might
have different priorities. Further research that includes
a more diverse set of donors is necessary to tackle ques-
tions of cultural and political factors underlying aid
funding as well as project objectives. Third, underlying
our analysis is a donor perspective which focuses on
donor characteristics as an explanatory variable for
project priorities. However, projects might also be re-
cipient driven in that certain recipients and problems
require certain project components. Fourth, another
limitation of our study is that our outcome measures
are self-reported and therefore be subject to biases such
as a social desirability and reporting style. Some donors
provided extensive information for each project while
others are more reluctant to make information avail-
able. This problem could be solved by conducting inter-
views with representatives of the donor organizations
in order to help establish a greater degree of accuracy
on this matter.
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Our analysis reveals that there are notable differences
between donor groups regarding the implementation of
maternal health projects. Our theoretical expectations
that were derived from numerous studies focusing on
funding patterns were only partly confirmed. This sug-
gests that project implementation follows somewhat
different rules than mere funding. Maternal health is a
central point in funding and project development of cor-
porations and foundations, but not of bilateral donors.
Therefore, it is premature to generalize beyond the issue
of maternal health. Theoretically, it would be interesting
to know if funding and project implementation vary sys-
tematically over all issues and which factors account for
the variation. Furthermore, future studies should provide
donor classifications on the basis of funding and projects
to give a more accurate picture of development and
health aid. Our analysis lends itself for a characterization of
implementation styles of different donors. These imple-
mentation styles give rise to some policy recommendations:
Since donor groups specialize in different contexts,
NGOs and governments working on development and
health aid may target donors groups that have special-
ized in certain issues.
There is a need for information-sharing between donor
groups in order to combine the project portfolio of each
donor group. This also enhances the possibility space of
projects. These can be recombined to find the most ap-
propriate solution to fight a given problem in health and
development policy.
The establishment of a global database with uniform
spending data of foundations and other private actors
would significantly help us to understand the increas-
ingly important role of private donors as direct opera-
tors, grant-givers or as members of a partnership.
Private aid is offering new business models and trans-
formative technologies which can complement the ap-
proaches of traditional donors. There is reason to believe
that both these strategies will provide good development
assistance, but only if coordination prevails. This co-
ordination needs to be based on the above-mentioned
information-sharing. When one actor is working in a
particular niche, he has specific knowledge and knows
about best practices and lessons learned. The global aid
architecture should endorse these specializations and
coordinate between certain actors. This has partially already
been done, for example, in disease-specific networks that
try to bring together all relevant actors working in a specific
field.
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